Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) affect 17–46% of Western countries, making coexistence with other liver diseases inevitable. We investigated the prevalence and clinical significance of NAFLD/NASH or the components of metabolic syndrome (Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Zachou, Kalliopi, Azariadis, Kalliopi, Lytvyak, Ellina, Snijders, Romée J.A.L.M., Takahashi, Atsushi, Gatselis, Nikolaos K., Robles, Mercedes, Andrade, Raul J., Schramm, Christoph, Lohse, Ansgar W., Tanaka, Atsushi, Drenth, Joost P.H., Montano-Loza, Aldo J., Dalekos, George N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339258/
https://www.ncbi.nlm.nih.gov/pubmed/37456672
http://dx.doi.org/10.1016/j.jhepr.2023.100778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339258/
https://www.ncbi.nlm.nih.gov/pubmed/37456672
http://dx.doi.org/10.1016/j.jhepr.2023.100778

Ejemplares similares